Secondary analysis of CANVAS, CREDENCE and DAPA-CKD: higher urinary EGF-creatinine ratio was associated with lower kidney risk (HR 0.87 per doubling; n=5978), and SGLT2 inhibitors attenuated its 1-year decline vs placebo by 6.7%; replicated in DAPA-CKD (n=2450).
Secondary analysisn = 5,978
Moedt et al. Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition